Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease

Published:2019-06-14 Issue:7 Volume:15 Page:527-539
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Franca Raffaella¹,Curci Debora²,Lucafò Marianna³⁴,Decorti Giuliana¹⁴,Stocco Gabriele⁵

Affiliation:

1. University of Trieste, Department of Medical, Surgical and Health Sciences, Trieste, Italy

2. University of Trieste, PhD Course in Reproductive and Developmental Sciences, Trieste, Italy

3. Centro di Riferimento Oncologico (CRO), Aviano, Italy

4. Institute for Maternal and Child Health I.R.C.C.S. Burlo Garofolo, Trieste, Italy

5. University of Trieste, Department of Life Sciences, Trieste, Italy

Funder

Ministero della Salute

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2019.1630378

Reference120 articles.

1. Future directions in inflammatory bowel disease management

2. Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease

3. Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

4. Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management

5. Ulcerative colitis

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical management of pediatric inflammatory bowel disease;Seminars in Pediatric Surgery;2024-04

2. Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases;Pediatric Rheumatology;2024-01-02

3. One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study;The Pharmacogenomics Journal;2023-04-04

4. Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases;Therapeutic Drug Monitoring;2023-04-03

5. One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study;2023-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3